US equities |
GOOGL $283.82 ▼-12.64% GOOG $282.32 ▼-12.29% MU $934.27 ▼-4.98% MSFT $530.14 ▼-0.16% AMZN $243.79 ▼-4.25% META $624.52 ▲+1.96% NVDA $213.66 ▼-0.80% AAPL $348.91 ▲+1.48%
FinancialContent

(OP:NUMIF)

0.0163 -0.0037 (-18.50%)
Delayed Quote Updated: 3:26 PM EDT, Oct 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about NUMIF

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Psychedelic Stock Gainers And Losers From April 13, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From April 12, 2023 ↗
 
Via Benzinga
News headline image
Check Out The Canadian Company Building On Several Vertical Psychedelics Businesses ↗
Mental healthcare company Numinus Wellness Inc. (OTCQX: NUMIF)’s new clinic licensing model, The Numinus Network offers independent practitioners the chance to own and operate their own clinic under... 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From April 11, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From April 10, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From April 7, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From April 6, 2023 ↗
 
Via Benzinga
News headline image
This Psychiatrist Calls Cannabis Is A Minor-League Psychedelic & Undervalued Investment Opportunity ↗
Cannabis is a psychedelic that belongs to the group of mind-manifesting substances, according to Dr. Julie Holland. "When you get high on cannabis, you can see your thoughts differently, and it can... 
Via Benzinga
News headline image
Psyched: Canada's Case For Psilocybin Access And Microdose Trial, US Reform Update, Battle With DEA & More ↗
Canadian Patients Demand Access To Psilocybin: Federal Lawsuit, Official Petition & Failing Mechanism A patient-led lawsuit against the Canadian government is claiming access to therapeutic psilocybin... 
Via Benzinga
News headline image
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Want To Become A Psychedelic-Assisted Therapist? This Company Offers A 'Pathway' Course ↗
Mental healthcare company Numinus Wellness Inc. (OTCQX: NUMIF) is launching a collection of psychedelic-assisted therapist (PAT) training courses for practitioners with multi-modal teaching methods. 
Via Benzinga
News headline image
In-Clinic Ketamine Businesses Are Shutting Down All Across The US, A Rising Trend? ↗
Closely following the announcement of what's to become of the new regulations for telehealth, including ketamine therapy, several of in-clinic treatment centers have announced they are closing their... 
Via Benzinga
News headline image
EXCLUSIVE: Bienstar Wellness Expands Ibogaine Treatment For Addiction To Curitiba, 3rd Brazilian City Covered By The Co. ↗
Bienstar Wellness, through its Brazilian clinics, Clínicas Beneva, will begin offering ibogaine treatments for addiction in Curitiba, the capital of the Paraná province in Brazil, starting in March. 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From March 9, 2023 ↗
 
Via Benzinga
News headline image
Numinus Wellness, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Will Canada Follow Australia And Approve Psychedelic Assisted Therapy? This CEO Believes It Will ↗
On this special yearend Trade To Black Podcast, TDR Founder Shadd Dales spoke with Payton Nyquvest, CEO of Numinus Wellness Inc. (OTC: NUMIF) regarding recent company events and those within the... 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From March 6, 2023 ↗
 
Via Benzinga
News headline image
Cybin, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From March 2, 2023 ↗
 
Via Benzinga
News headline image
Cybin, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 28, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 27, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 24, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 23, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 22, 2023 ↗
 
Via Benzinga
News headline image
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More ↗
Psychedelics States Reform: Utah, Iowa, Missouri and Oklahoma’s New Bills; Hawaii, Arizona and Washington's Green Lights, New Hampshire's Setback Earlier this week, three bills were introduced and... 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 21, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 20, 2023 ↗
 
Via Benzinga
News headline image
ATAI Life Sciences, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Numinus Debuts 3rd Research Site In US, Touts Faster Services & More Participants ↗
Numinus Wellness (OTCQX: NUMIF) expanded its clinical research capabilities into Phoenix, where the psychedelic-assisted therapy provider currently operates mental health clinics.  
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >